A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

In the study, "Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice," published in Science Translational Medicine, researchers ...

A UC Berkeley-led research team discovered a new method of administering treatment for heart diseases, with the aid of a chip ...

A research team from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and Tsinghua University has developed a new mRNA vaccine delivery method that could improve ...

The findings, demonstrated in mouse models and isolated human brain tissue, could expand treatment options for neurological and psychiatric diseases. (Nanowerk News) Scientists at the Icahn School of ...

A new material could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger unwanted immune responses in some people. (Nanowerk ...

UNLV scientists successfully introduced nanoparticles with messenger RNA into the pancreas for the first time with 99% accuracy.